Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001193125-26-396892

Senior VP, Finance and PAO sold 7,842 shares at an average $3.32 ($26,072)

  • Senior VP, Finance and PAO bought 509 shares at $3.88 ($1,973)

From the SEC's structured data for this filing

Trades in this filing

Nemec Sarah · Senior VP, Finance and PAO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-05 Purchase : show line 1 in the form +509 $3.88 $1,973 1,924 D
2026-09-16 Sale : show line 2 in the form −843 $3.77 $3,181 24,081 D
2026-09-17 Sale : show line 3 in the form −2,922 $3.32 $9,696 21,159 D
2026-09-18 Sale : show line 4 in the form −4,077 $3.24 $13,195 17,082 D
Open-market purchases · 509 sh · avg $3.88 · $1,973
Open-market sales · 7,842 sh · avg $3.32 · $26,072
Loading xslF345X06/ownership.xml…